Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy
- PMID: 15525877
- DOI: 10.1016/s1262-3636(07)70126-x
Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy
Abstract
Objective: Hepatocyte growth factor, also know as the scatter factor (HGF/SF) has been involved in the etiopathogenesis of proliferative diabetic retinopathy (PDR). To further explore this issue we have determine the intravitreous levels of HGF/SF taking into account the problems that could lead to misinterpretation of the results when the vitreous fluid is used to indirectly explore the events that are taking place in the retina. In addition, the relationship between HGF/SF and vascular cell adhesion molecule 1 (VCAM-1) was also investigated.
Patients and methods: Serum and vitreous samples were obtained during vitrectomy from 22 diabetic patients with PDR and 25 non-diabetic control subjects. Patients in whom intravitreous hemoglobin was detectable were excluded. A correction for plasma levels of either HGF/SF and VCAM-1 and intravitreal proteins was performed.
Results: Vitreal levels of both HGF/SF and VCAM-1 were higher in patients with PDR in comparison with the control group (p<0.001 and p=0.003, respectively). However, after correcting for total vitreal proteins both HGF/SF and VCAM-1 (ng/mg of proteins) were lower in diabetic patients than in non-diabetic control subjects (p=0.03 and p<0.0001, respectively). No relationship between the vitreous levels of either HGF/SF or VCAM-1 with PDR activity was detected. Finally, a correlation between the vitreal levels of HGF/SF and VCAM-1 was observed in diabetic patients (r=0.61, p=0.005) but not in the control group.
Conclusion: Our results suggest that intraocular production of HGF/SF might be more important in mediating inflammatory and fibroproliferative processes rather than in angiogenesis itself.
Similar articles
-
Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.Diabetes Care. 2001 Mar;24(3):516-21. doi: 10.2337/diacare.24.3.516. Diabetes Care. 2001. PMID: 11289478
-
Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.Diabetes Res Clin Pract. 2006 Jan;71(1):36-44. doi: 10.1016/j.diabres.2005.05.017. Epub 2005 Jul 18. Diabetes Res Clin Pract. 2006. PMID: 16029908
-
Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy.Br J Ophthalmol. 2000 Jul;84(7):732-5. doi: 10.1136/bjo.84.7.732. Br J Ophthalmol. 2000. PMID: 10873984 Free PMC article.
-
Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.Diabetes Care. 1998 Oct;21(10):1759-63. doi: 10.2337/diacare.21.10.1759. Diabetes Care. 1998. PMID: 9773744
-
Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.Diabetes Care. 2002 Dec;25(12):2282-6. doi: 10.2337/diacare.25.12.2282. Diabetes Care. 2002. PMID: 12453974
Cited by
-
Novel targets against retinal angiogenesis in diabetic retinopathy.Curr Diab Rep. 2012 Aug;12(4):355-63. doi: 10.1007/s11892-012-0289-0. Curr Diab Rep. 2012. PMID: 22638940 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous